A case of post‐COVID‐19 myalgic encephalomyelitis/chronic fatigue syndrome characterized by post‐exertional malaise and low serum acylcarnitine level

COVID‐19 afflicts patients with acute symptoms and longer term sequelae. One of the sequelae is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is often difficult to diagnose, having no established tests. In this article, we synthesize information from literature reviews on patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Jinushi, Ryuhei, Nishiguchi, Sho, Masuda, Sakue, Sasaki, Akiko, Koizumi, Kazuya, Ryozawa, Shomei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9913186/
https://www.ncbi.nlm.nih.gov/pubmed/36789311
http://dx.doi.org/10.1002/ccr3.6930
Descripción
Sumario:COVID‐19 afflicts patients with acute symptoms and longer term sequelae. One of the sequelae is myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS), which is often difficult to diagnose, having no established tests. In this article, we synthesize information from literature reviews on patients with ME/CSF that developed after recovery from COVID‐19.

Ejemplares similares